Goal set to exceed $140 million of NGS-related sales in 2018, up from over $115 million in 2017 New Enterprise Genomics Services to offer gene panel customization capabilities to customers GeneReader NGS System plans include enhanced chemistry, more powerful gene panels Hilden, Germany, and Germantown, Maryland, January 8, 2018 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt […]
Companies Target Review Aimed at Molecular Oncology and Hereditary Diseases SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a […]
SEATTLE and TOKYO — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Riken Genesis, a subsidiary of Sysmex Corporation (TOKYO, 6869), today announced that they have entered into a partnership to introduce nCounter-based diagnostic assays in Japan. Under this agreement, NanoString and Riken Genesis will collaborate to register, obtain reimbursement and […]
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that it has entered into a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) focused on optimizing BLI’s proprietary BeaconTMOptofluidic platform with the goal of helping to accelerate Pfizer’s monoclonal antibody (mAb) […]
Founded in 1999，and with the vision of using genomics to benefit mankind，BGI has since become the largest genomic organization in the world. With the rapid development of genetic testing, BGI, the industry pioneer, is willing to work together with innovators around the world to unlock the power of genome，by building an open biological research, transformation and […]
SAN DIEGO — Maravai LifeSciences (“Maravai”), a leader in providing specialty reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced the acquisition of Sterling, VA based Glen Research Corporation (“Glen Research”). Founded in 1987, Glen Research is a recognized leader in providing a wide range of reagents used in the synthesis of DNA and RNA. Since its earliest […]
The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, today announced a collaboration to develop a novel analytical platform to improve the rapid analysis of the glycosylation profiles of biotherapeutics. This is a critical quality attribute which is important for the efficacy and safety of these molecules. The consortium brings […]
Nan Fung Life Sciences and Madryn Asset Management join iCarbonX in investing to accelerate SomaLogic’s unique precision health insights delivery business Boulder, CO – SomaLogic announced today that it has capped its $200 million funding round, anchored by iCarbonX with substantial investments from Nan Fung Life Sciences and Madryn Asset Management. The successful round will accelerate SomaLogic’s […]
AMSBIO has introduced recombinant Wnt3a with a new Wnt stabilizer that significantly extends the activity of this protein in serum-free medium from a half-life of just 2 hours to around 30 hours. Wnt-3a is a protein that is encoded by the Wnt3a gene. The Wnt gene family consists of structurally related genes that encode secreted […]
Investment led by Foresite Capital with strategic investment by Microsoft will support expansion in translational informatics, clinical trials, and broadened use of biomedical data MOUNTAIN VIEW, Calif.–DNAnexus, Inc., the global leader in biomedical informatics and data management, today announced closing a $58 million financing led by new investor Foresite Capital with strategic investment from Microsoft […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
